Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings

• click to rate

  Posted by Two Blokes Apr 16 - Filed in Stock - 2 views
  
  Strength in Analytical Instruments and Specialty Diagnostics segments is likely to have driven Thermo Fisher's first-quarter 2025 performance.